FranΓ§ais| Metric | Danaher Corporation | Thermo Fisher Scientific | Edge |
|---|---|---|---|
| Price | $216 | $631 | |
| Median target (12m) | $230 (+7%) | $600 (-5%) | |
| Analyst reliability (1y) | 45% | 43% | π’ DHR |
| Avg gain / call (1y) | +12% | +14% | |
| P/E | 38.4 | 34.1 | π΅ TMO |
| $1000 invested (10y ago) | $3,175 | $3,881 | π΅ TMO |
| Year | DHR | TMO | Winner |
|---|---|---|---|
| 2026 | -10% | -4% | π΅ TMO |
| 2025 | +1% | -1% | π’ DHR |
| 2024 | -18% | -7% | π΅ TMO |
| 2023 | +15% | +5% | π’ DHR |
| 2022 | -10% | -0% | π΅ TMO |
| 2021 | +25% | +21% | π’ DHR |
| 2020 | +52% | +55% | π΅ TMO |
| 2019 | +14% | +12% | π’ DHR |
| 2018 | +30% | +24% | π’ DHR |
| 2017 | +14% | +32% | π΅ TMO |
| 2016 | +26% | +22% | π’ DHR |
Over ~10 years, Danaher Corporation returned $3,175 on $1000 vs $3,881 for Thermo Fisher Scientific, and Danaher Corporation has better analyst reliability. Not advice: also check valuation (P/E) and your horizon.
Over ~10 years, Thermo Fisher Scientific wins ($3,175 vs $3,881 on $1000 invested, price return excluding dividends).
On P/E, Thermo Fisher Scientific is cheaper (38.4 vs 34.1). A lower P/E isn't always a better deal (growth matters).
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Past price performance (excluding dividends). Data: Yahoo Finance.